12 Health Care Stocks Moving In Tuesday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Tuesday's pre-market session, several health care stocks experienced significant movements. Gainers included Abpro Holdings (ABP) with a 90.1% rise to $2.89, Quince Therapeutics (QNCX) up 65.53% to $0.22, and Phio Pharma (PHIO) increasing 23.33% to $1.11. Conversely, Barinthus Biotherapeutics (BRNS) saw a sharp decline of 61.8% to $0.27, while Tectonic Therapeutic (TECX) fell 42.82% to $14.2. Other notable losers included Becton Dickinson (BDX), down 19.48% to $167.0, following Q1 earnings release.
Gainers
- Abpro Hldgs (NASDAQ:ABP) stock rose 90.1% to $2.89 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
- Quince Therapeutics (NASDAQ:QNCX) stock rose 65.53% to $0.22. The company's market cap stands at $7.2 million.
- Phio Pharma (NASDAQ:PHIO) shares rose 23.33% to $1.11. The company's market cap stands at $9.6 million.
- Microbot Medical (NASDAQ:MBOT) shares increased by 16.3% to $2.14. The company's market cap stands at $123.5 million.
- Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 13.1% to $1.64. The market value of their outstanding shares is at $39.2 million.
- Biomerica (NASDAQ:BMRA) shares moved upwards by 10.59% to $2.4. The company's market cap stands at $6.5 million.
Losers
- Barinthus Biotherapeutics (NASDAQ:BRNS) shares fell 61.8% to $0.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $28.8 million.
- Tectonic Therapeutic (NASDAQ:TECX) shares decreased by 42.82% to $14.2. The company's market cap stands at $464.7 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares declined by 24.17% to $0.46. The company's market cap stands at $2.1 million.
- Becton Dickinson (NYSE:BDX) shares fell 19.48% to $167.0. The company's market cap stands at $59.0 billion. As per the press release, Q1 earnings came out yesterday.
- Silexion Therapeutics (NASDAQ:SLXN) stock declined by 16.58% to $1.46. The company's market cap stands at $5.4 million.
- CollPlant Biotechnologies (NASDAQ:CLGN) shares fell 13.09% to $0.56. The market value of their outstanding shares is at $8.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.